LIVE/VIRTUAL ACTIVITIES

Bio Ascend – Designing CME Solutions For a Virtual World, Our Live and Virtual CME Activities Are Designed to Keep HCPs Educated.

Bio Ascend helps healthcare providers (HCPs) like you stay educated by providing the CME resources you need for continuing education. Our vast selection of activities is devoted entirely to solid tumor and hematologic malignancies – with engaging options in both in-person and virtual environments. Activities feature leading experts discussing the latest data and how to apply it to clinical practice, providing you with critical insight and direction on how to incorporate therapeutic advancements into your practice.

Satellite Symposia:
Regimen Choice and Newly Approved Agents in Relapsed/Refractory Multiple Myeloma

September 10, 2021 – Live/Virtual
Time: 6:15 AM – 7:45 AM CDT

There are no fees to register for this symposium

This live satellite symposium will take place in conjunction with the 2021 Society of Hematologic Oncology Annual Meeting and will be presented by three renowned experts actively engaged in the care of patients with relapsed/refractory multiple myeloma. This symposium will also be live-streamed for those who may not be able to attend in person.

Not an official program of the SOHO 2021 Annual Meeting. Not sponsored or endorsed by the Society of Hematologic Oncology

Agenda
6:15 PM
Welcome, Introductions, and Pre-session Survey
6:20 PM
Regimen Choice: Doublet vs Triplet
6:35 PM

Utility of MRD in Clinical Practice

6:50 PM

Targeting BCMA

  • CAR T Cells
  • Bispecific Antibodie
  • Antibody-drug Conjugate
7:10 PM

Incorporating newly approved agents into clinical practice

  • Available clinical evidence
  • Managing Novel AE profile
7:30 PM
Panel Discussion and Audience Q&A
7:40 PM
Recap of Key Points and Post-Session Survey
7:45 PM
Program Adjourns

Symposium Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University

Faculty

Thomas Martin, MD
University of California San Francisco

Krina Patel, MD, MSc
UT MD Anderson Cancer Center

Satellite Symposia:
Regimen Choice and Newly Approved Agents in Relapsed/Refractory Multiple Myeloma

September 10, 2021 – Live/Virtual
Time: 6:15 AM – 7:45 AM CDT

There are no fees to register for this symposium

This live satellite symposium will take place in conjunction with the 2021 Society of Hematologic Oncology Annual Meeting and will be presented by three renowned experts actively engaged in the care of patients with relapsed/refractory multiple myeloma. This symposium will also be live-streamed for those who may not be able to attend in person.

Not an official program of the SOHO 2021 Annual Meeting. Not sponsored or endorsed by the Society of Hematologic Oncology

Symposium Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University

Faculty

Thomas Martin, MD
University of California San Francisco

Krina Patel, MD, MSc
UT MD Anderson Cancer Center

Agenda
6:15 PM
Welcome, Introductions, and Pre-session Survey
6:20 PM
Regimen Choice: Doublet vs Triplet
6:35 PM

Utility of MRD in Clinical Practice

6:50 PM

Targeting BCMA

  • CAR T Cells
  • Bispecific Antibodie
  • Antibody-drug Conjugate
7:10 PM

Incorporating newly approved agents into clinical practice

  • Available clinical evidence
  • Managing Novel AE profile
7:30 PM
Panel Discussion and Audience Q&A
7:40 PM
Recap of Key Points and Post-Session Survey
7:45 PM
Program Adjourns